SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABAXIS - A SLEEPER?
ABAX 83.000.0%Aug 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Jones who wrote (3)6/9/1996 4:26:00 PM
From: David Bogdanoff   of 19
 
Dan-
Thanks for the info. I did a quick check on these companies. Diametrics Medical's system analyzes blood gases, not blood chemistries. It's role is more complementary than competitive. I-STAT is a more complex situation and I could not complete my research on this company. Its system also analyzes blood gases in a mobile hand-held device, useful in critical or intense care settings. I don't think, but am not certain, that it performs blood chemistries. Certainly it does not perform a panel of 8 or 12 blood chemistries as ABAXIS's Piccolo system does. Nor are these companies in the vet market. The technology to measure blood gases would be quite different from a technology to measure blood chemistries and I don't think it would be easy to combine two such technologies in a single system although it would be desirable for doctors/nurses to have both capabilities available at the point-of-care of a patient. Insofar as such systems are avaible at POC, there is no need for a separate nearby expensive laboratory to deliver the same service. Blood-gas measurement systems and blood chemistry panels are complementary and support each other's acceptance by the medical communities.
The big challenge is getting the medical community to accept the POC concept to the point that they take the big step of eliminating existing labs and going with POC system. I-STAT seems to have gone further in this direction by conducting hospital cost/performance studies. This is a $12 billion world-wide market; it is sufficient to get a piece of the action to see a profit.
David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext